Syreeta L. Tilghman
- Cancer Research top 10%
- MicroRNA in disease regulation 4
- Genetics top 10%
- Estrogen and related hormone effects 19
- Oncology top 10%
- Cancer Cells and Metastasis 9
- Cancer-related Molecular Pathways 5
- HER2/EGFR in Cancer Research 3
- Biochemistry top 10%
- Toxicology top 10%
- Bioactive Compounds and Antitumor Agents 3
-
- Genomics, phytochemicals, and oxidative stress 4
-
- Phytoestrogen effects and research 3
- Co-authors
- Matthew E. BurowJohn A. McLachlanMelyssa R. BrattonGauri SabnisLyndsay V. RhodesLuciana F. MacedoFlorastina Payton‐StewartAngela Brodie
- Cited by
- Cancer ResearchGeneticsOncology
- Journals
- Cancer Research (3 papers)Anticancer Research (2 papers)International Journal of Molecular Sciences (2 papers)
- Partner nations
- United States
In The Last Decade
Syreeta L. Tilghman
33 papers receiving 889 citations
Peers
Comparison fields: 5 of 84
- Cancer Research 248
- Genetics 300
- Oncology 277
- Biochemistry 50
- Toxicology 28
Countries citing papers authored by Syreeta L. Tilghman
This map shows the geographic impact of Syreeta L. Tilghman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Syreeta L. Tilghman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Syreeta L. Tilghman more than expected).
Fields of papers citing papers by Syreeta L. Tilghman
This network shows the impact of papers produced by Syreeta L. Tilghman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Syreeta L. Tilghman. The network helps show where Syreeta L. Tilghman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Syreeta L. Tilghman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2023 | 4 | |
| 3 | 2021 | 5 | |
| 4 | 2021 | 8 | |
| 5 | 2021 | 8 | |
| 6 | 2020 | 1 | |
| 7 | 2014 | 14 | |
| 8 | 2013 | 51 | |
| 9 | 2013 | 10 | |
| 10 | 2013 | 21 | |
| 11 | 2012 | 20 | |
| 12 | 2012 | 17 | |
| 13 | 2012 | 120 | |
| 14 | 2011 | 30 | |
| 15 | 2011 | 45 | |
| 16 | 2011 | 13 | |
| 17 | Glyceollins, a Novel Class of Antiestrogenic Phytoalexins | 2010 | 11 |
| 18 | 2010 | 11 | |
| 19 | 2010 | 29 | |
| 20 | 2009 | 91 |
About Syreeta L. Tilghman
Syreeta L. Tilghman is a scholar working on Toxicology, Genetics, Oncology, Biochemistry and Cancer Research, having authored 34 papers that have together received 913 indexed citations. Recurring topics across this work include Estrogen and related hormone effects (19 papers), Cancer Cells and Metastasis (9 papers), Cancer-related Molecular Pathways (5 papers), Genomics, phytochemicals, and oxidative stress (4 papers), MicroRNA in disease regulation (4 papers), Bioactive Compounds and Antitumor Agents (3 papers), Phytoestrogen effects and research (3 papers) and HER2/EGFR in Cancer Research (3 papers). The work is most often cited by research in Cancer Research (248 citations), Genetics (300 citations), Oncology (277 citations), Biochemistry (50 citations) and Toxicology (28 citations). Syreeta L. Tilghman has collaborated with scholars based in United States. Frequent co-authors include Matthew E. Burow, John A. McLachlan, Melyssa R. Bratton, Gauri Sabnis, Lyndsay V. Rhodes, Luciana F. Macedo, Florastina Payton‐Stewart, Angela Brodie, Yun Qiu and Zhiyong Guo. Their work appears in journals such as Cancer Research, Anticancer Research, International Journal of Molecular Sciences, Biomolecules and Journal of Health Care for the Poor and Underserved.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.